XBiotech (XBIT) Receivables (2020 - 2025)
XBiotech (XBIT) posted quarterly Receivables of $450000.0 for Q3 2025, down 38.36% year-over-year from $730000.0 in Q3 2024, and down 6.25% quarter-over-quarter from $480000.0 in Q2 2025.
XBiotech (XBIT) Receivables (2020 - 2025) Analysis & Trends
XBiotech's Receivables history runs 6 years deep, the most recent figure standing at $450000.0 for Q3 2025.
- In Q3 2025, Receivables fell 38.36% year-over-year to $450000.0; the TTM figure through Sep 2025 stood at $450000.0 (down 38.36% YoY), while the FY2024 annual figure was $1.4 million, down 18.6% from the prior year.
- Receivables for Q3 2025 stood at $450000.0, down from $480000.0 in the prior quarter.
- The five-year high for Receivables was $2.4 million in Q4 2022, with the low at $25000.0 in Q2 2021.
- The 5-year median for Receivables is $870000.0 (2024), against an average of $940000.0.
- The sharpest annual moves came in 2021 and 2022: Receivables sank 99.88% in 2021, then soared 3377.27% in 2022.
- XBiotech's Receivables stood at $44000.0 in 2021, then surged by 5427.27% to $2.4 million in 2022, then declined by 29.28% to $1.7 million in 2023, then dropped by 18.6% to $1.4 million in 2024, then plunged by 67.86% to $450000.0 in 2025.
- Business Quant data shows XBIT's Receivables at $450000.0 in Q3 2025, $480000.0 in Q2 2025, and $480000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 912.74 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 215.33 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.09 Bn |
| 10 | XBiotech | 68.90 Mn | 68.90 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 450,000.00 |
| Jun 30, 2025 | 480,000.00 |
| Mar 31, 2025 | 480,000.00 |
| Dec 31, 2024 | 1.40 Mn |
| Sep 30, 2024 | 730,000.00 |
| Jun 30, 2024 | 870,000.00 |
| Mar 31, 2024 | 870,000.00 |
| Dec 31, 2023 | 1.72 Mn |
| Sep 30, 2023 | 881,000.00 |
| Dec 31, 2022 | 2.43 Mn |
| Sep 30, 2022 | 1.53 Mn |
| Mar 31, 2022 | 500,000.00 |
| Sep 30, 2021 | 44,000.00 |
| Jun 30, 2021 | 25,000.00 |
| Mar 31, 2021 | 1.69 Mn |
| Dec 31, 2020 | 4.11 Mn |
| Sep 30, 2020 | 6.06 Mn |
| Jun 30, 2020 | 20.68 Mn |
| Mar 31, 2020 | 9.68 Mn |